REVATIO 10 MG/ML POLVO PARA SUSPENSION ORAL

Описание товара

About REVATIO 10 MG/ML POLVO PARA SUSPENSION ORAL

REVATIO 10 MG/ML POLVO PARA SUSPENSION ORAL is a pharmaceutical preparation containing the active substance sildenafilo, formulated as a powder for oral suspension. The product is intended for use in the treatment of erectile dysfunction, providing a convenient liquid form that can be mixed with a suitable diluent before administration. The suspension is designed to deliver a precise dose of 10 mg of sildenafilo per milliliter, allowing for accurate titration and ease of use in clinical settings. The formulation is manufactured under strict quality control standards to ensure purity, potency, and safety for patients. The product is supplied in a sealed container with clear instructions for reconstitution and storage, ensuring that healthcare professionals can prepare the suspension accurately and maintain its stability.

Key Benefits & Uses

• Provides a liquid formulation that facilitates accurate dosing for patients who have difficulty swallowing tablets.
• Delivers a consistent 10 mg/mL concentration of sildenafilo, enabling precise titration to individual patient needs.
• Supports the management of erectile dysfunction by improving blood flow to the genital area.

Active Ingredient & Action

The active ingredient, sildenafilo, is a phosphodiesterase type 5 inhibitor that works by relaxing smooth muscle tissue in the corpus cavernosum, thereby increasing blood flow during sexual stimulation. This mechanism helps patients achieve and maintain an erection sufficient for sexual activity. The drug is absorbed orally and reaches peak plasma concentrations within a few hours, providing a therapeutic effect that lasts for several hours after ingestion.

Important Notes

Patients should follow the reconstitution instructions carefully to ensure the correct concentration of the suspension. The product should be stored in a cool, dry place and protected from light. Healthcare providers should assess each patient for contraindications, such as concurrent use of nitrates or severe cardiovascular disease, before prescribing this medication. The suspension should be used only as directed by a qualified healthcare professional, and patients should be advised to report any adverse reactions promptly.